4.3 Letter

Portal hypertension, advanced hepatocellular carcinoma and therapy by atezolizumab-bevacizumab: A menage a trois !

Publisher

ELSEVIER MASSON, CORP OFF
DOI: 10.1016/j.clinre.2021.101785

Keywords

Atezolizumab-Bevacizumab; HCC; Variceal bleeding; Portal hypertension

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available